Back to ARNA Stock Lookup

Arena Pharma (ARNA) – Company Press Releases

Jan 12, 2016 04:05 PM Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia
Jan 7, 2016 08:00 AM Arena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference
Dec 1, 2015 08:00 AM Eisai and Arena Pharmaceuticals Announce Completion of Enrollment in BELVIQ® (lorcaserin HCI) CAMELLIA-TIMI 61 Study
Nov 30, 2015 08:00 AM Eisai and Arena Pharmaceuticals Announce FDA Acceptance of New Drug Application for Extended Release Formulation of Lorcaserin
Nov 24, 2015 08:00 AM Arena Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare Conference
Nov 19, 2015 08:00 AM Arena Pharmaceuticals to Host Analyst & Investor Day on December 3rd
Nov 10, 2015 04:00 PM Arena Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update
Nov 4, 2015 08:00 AM Arena Pharmaceuticals to Host Third Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, November 10
Nov 2, 2015 08:00 AM Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at 2015 Annual Obesity Week Meeting
Oct 29, 2015 08:00 AM Arena Pharmaceuticals Initiates a Phase 1b Clinical Trial of APD371
Oct 27, 2015 04:00 PM Arena Pharmaceuticals Announces New Strategic Focus and Cost Reduction Plan
Oct 27, 2015 08:00 AM Arena Pharmaceuticals Issued Additional Patent Covering BELVIQ® (lorcaserin HCl) by United States Patent and Trademark Office
Oct 19, 2015 03:44 PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Claims Against Arena Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm
Oct 16, 2015 05:54 PM Glancy, Prongay & Murray LLP Commences Investigation on Behalf of Arena Pharmaceuticals, Inc. Investors
Oct 5, 2015 04:15 PM Arena Pharmaceuticals Announces Retirement of President and CEO
Sep 24, 2015 08:00 AM Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings
Sep 3, 2015 08:00 AM Arena Pharmaceuticals to Present at the Wells Fargo 2015 Healthcare Conference
Aug 5, 2015 04:01 PM Arena Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Jul 30, 2015 08:00 AM Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5
Jul 29, 2015 08:00 AM Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases
Jun 16, 2015 04:30 PM Arena Pharmaceuticals Announces the Departure of Chief Financial Officer
Jun 4, 2015 01:30 PM Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions
May 26, 2015 08:00 AM Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference
May 14, 2015 08:00 AM Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings
May 11, 2015 04:07 PM Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results
May 11, 2015 04:01 PM Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor
May 8, 2015 08:00 AM Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference
May 7, 2015 08:00 AM Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11
Apr 29, 2015 08:00 AM Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371
Apr 10, 2015 08:00 AM Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin
Apr 9, 2015 08:00 AM Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference
Apr 7, 2015 08:00 AM Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office
Mar 12, 2015 12:00 AM KERAMIKA 2015: Window for the Indonesian Ceramic Industry
Oct 31, 2014 08:00 AM Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting

Back to ARNA Stock Lookup